Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01951066 · ClinicalTrials.gov registry record · Phase 2
Diabetic Macular Edema Treated With Ozurdex (DMEO)
A Phase 2 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT01951066: Completed Phase 2 study, sponsored by Johns Hopkins University.
NCT01951066 is a Phase 2 study that has completed, run by Johns Hopkins University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01951066, a Phase 2 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
To measure various pro-permeability factors in the aqueous humor of patients with persistent/recurrent diabetic macular edema
Interventions
- DRUG Dexamethasone Implant
- DRUG Anti-VEGF injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01951066
The ClinicalTrials.gov registry entry for NCT01951066 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone Implant is the first listed.
NCT01951066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01951066 about?
NCT01951066 is a clinical study titled "Diabetic Macular Edema Treated With Ozurdex (DMEO)". To measure various pro-permeability factors in the aqueous humor of patients with persistent/recurrent diabetic macular edema
What is the current status of trial NCT01951066?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2013-10. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01951066?
The interventions under investigation include: Dexamethasone Implant (DRUG), Anti-VEGF injection (DRUG).
Who is sponsoring clinical trial NCT01951066?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.